[New therapeutic strategy for malignant lymphoma targeting cell surface antigens]

HLA-DPB1 mismatch induces a graft-versus-leukemia effect without severe acute GVHD after single-unit umbilical cord blood transplantation.

Leukemia·2017

Impact of graft-versus-host disease on outcomes after unrelated cord blood transplantation.

Leukemia·2016

Sinusoidal obstruction syndrome after allogeneic hematopoietic stem cell transplantation: Incidence, risk factors and outcomes.

Bone marrow transplantation·2015

Risk factors and prognosis of hepatic acute GvHD after allogeneic hematopoietic cell transplantation.

Bone marrow transplantation·2015

Pre-transplant diabetes mellitus is a risk factor for non-relapse mortality, especially infection-related mortality, after allogeneic hematopoietic SCT.

Bone marrow transplantation·2015

Decision analysis for donor selection in stem cell transplantation-HLA-8/8 allele-matched unrelated donor vs HLA-1 AG mismatched related donor.

Blood cancer journal·2014

[Clinical management of familial platelet disorder with associated myeloid malignancies: at the crossroads of hematology and clinical genetics].

[Rinsho ketsueki] The Japanese journal of clinical hematology·2026

[DDX41-mutated myeloid neoplasms].

[Rinsho ketsueki] The Japanese journal of clinical hematology·2026

[Clinical significance of germline pathogenic variants associated with hematologic malignancies].

[Rinsho ketsueki] The Japanese journal of clinical hematology·2026

[Future directions in clinical development of first-line therapy for diffuse large B-cell lymphoma].

[Rinsho ketsueki] The Japanese journal of clinical hematology·2026

[Novel therapeutic strategies to separate GVHD from GVL based on GVHD pathophysiology and mechanisms of leukemia relapse].

[Rinsho ketsueki] The Japanese journal of clinical hematology·2026

[New developments in cord blood transplantation: immunological characteristics and strategies for relapse prevention].

[Rinsho ketsueki] The Japanese journal of clinical hematology·2026

Advances in γδ T Cells: Cutaneous Biology and Therapeutic Potential for Skin Neoplasms.

The Journal of dermatology·2026

Revisiting tumor immunogenicity through the lens of mutant p53: Implications for cancer immunotherapy.

Apoptosis : an international journal on programmed cell death·2026

Intersession reliability of transcranial magnetic stimulation measures of interhemispheric inhibition.

Neuroscience·2026

Immune profiling by bulk RNA-seq and multiplex immunofluorescence imaging across multiple cancer types.

Frontiers in oncology·2026

Brain barriers at the crossroads of glioma immune surveillance and immunotherapy response.

Nature reviews. Cancer·2026

Circulating levels of TL1A and its decoy receptor DcR3 in systemic sclerosis.

Clinical rheumatology·2026

Related Experiment Videos

[New therapeutic strategy for malignant lymphoma targeting cell surface antigens]

Related Concept Videos

HLA-DPB1 mismatch induces a graft-versus-leukemia effect without severe acute GVHD after single-unit umbilical cord blood transplantation.

Impact of graft-versus-host disease on outcomes after unrelated cord blood transplantation.

Sinusoidal obstruction syndrome after allogeneic hematopoietic stem cell transplantation: Incidence, risk factors and outcomes.

Risk factors and prognosis of hepatic acute GvHD after allogeneic hematopoietic cell transplantation.

Pre-transplant diabetes mellitus is a risk factor for non-relapse mortality, especially infection-related mortality, after allogeneic hematopoietic SCT.

Decision analysis for donor selection in stem cell transplantation-HLA-8/8 allele-matched unrelated donor vs HLA-1 AG mismatched related donor.

[Clinical management of familial platelet disorder with associated myeloid malignancies: at the crossroads of hematology and clinical genetics].

[DDX41-mutated myeloid neoplasms].

[Clinical significance of germline pathogenic variants associated with hematologic malignancies].

[Future directions in clinical development of first-line therapy for diffuse large B-cell lymphoma].

[Novel therapeutic strategies to separate GVHD from GVL based on GVHD pathophysiology and mechanisms of leukemia relapse].

[New developments in cord blood transplantation: immunological characteristics and strategies for relapse prevention].

Advances in γδ T Cells: Cutaneous Biology and Therapeutic Potential for Skin Neoplasms.

Revisiting tumor immunogenicity through the lens of mutant p53: Implications for cancer immunotherapy.

Intersession reliability of transcranial magnetic stimulation measures of interhemispheric inhibition.

Immune profiling by bulk RNA-seq and multiplex immunofluorescence imaging across multiple cancer types.

Brain barriers at the crossroads of glioma immune surveillance and immunotherapy response.

Circulating levels of TL1A and its decoy receptor DcR3 in systemic sclerosis.

Related Experiment Videos

[New therapeutic strategy for malignant lymphoma targeting cell surface antigens]

Related Concept Videos

Related Articles